Middle Ear

Otic polyp

October 31, 2012     Lester D.R. Thompson, MD
article

An uncommon entity, otic polyp arises in response to a long-standing inflammatory or infectious process of the middle ear, most often in young boys.

Middle ear atelectasis

October 31, 2012     Min-Tsan Shu, MD; Kang-Chao Wu, MD; Yu-Chun Chen, MD
article

Tympanic membrane retraction caused by long-term eustachian tube dysfunction may lead to erosion of the ossicles and cholesteatoma.

Cholesterol granuloma

October 8, 2012     Joseph A. Ursick, MD; Derald E. Brackmann, MD
article

 Cholesterol granulomas can cause bony expansion and typically become symptomatic when they encroach upon adjacent cranial nerves.

Complications of chronic suppurative otitis media: A left otogenic brain abscess and a right mastoid fistula

October 4, 2012     Yok Kuan Chew, MS; Jack Pein Cheong, MBBS; Abdullah Khir, MS; Sushil Brito-Mutunayagam, MS; Narayanan Prepageran, FRCS
article

Abstract

Otogenic brain abscess and postauricular fistula are complications of chronic suppurative otitis media. We describe a rare case of bilateral chronic suppurative otitis media that caused a left temporal lobe abscess and a right mastoid fistula.

Interhemispheric subdural abscess: A rare complication of atticoantral ear disease

August 10, 2012     Borlingegowda Viswanatha, MS, DLO
article

Abstract

A 14-year-old girl who had been experiencing ear discharge for the previous 3 years was referred to a tertiary care center for management of a 3-day history of severe headache and vomiting. Otolaryngologic examination revealed the presence of an atticoantral type of ear disease on the left side. Computed tomography detected an interhemispheric subdural abscess that had originated on the left side. The patient was initially treated with antibiotics, and she later underwent a mastoidectomy to clear the ear disease. She recovered without complications. Subdural empyema is the rarest complication of otitis media, and it is very rarely seen in an interhemispheric setting.

Topical mitomycin C application before myringotomy and ventilation tube insertion: Does it affect the final outcome?

August 10, 2012     Ahmed Hesham, MD; Ayman Hussien, MD; Ahmed Hussein, MD
article

Abstract

Previous animal studies have shown that the topical application of mitomycin C is safe and effective in prolonging the patency of myringotomy openings in ears that have not received a ventilation tube. We conducted a randomized, controlled study in humans to determine if this treatment would make a difference in outcomes when a ventilation tube is inserted. To that end, we prospectively studied a group of patients with resistant otitis media with effusion who underwent bilateral myringotomy and ventilation tube insertion. Our original study population was made up of 55 children aged 2 to 12 years; 15 of these patients were lost to follow-up, leaving us with 40 patients and 80 ears. Each patient served as his or her own control, as mitomycin C was applied to the tympanic membrane on one side just prior to myringotomy creation and normal saline was applied to the other side. Our main outcomes measures were the duration of tube placement (i.e., the length of time before extrusion of the tube) and the incidence of other early and late postoperative complications. We found no statistically significant difference between the mitomycin C-treated ears and the control ears in any of these parameters. We conclude that the use of mitomycin C prior to myringotomy and ventilation tube insertion is not worthwhile.

Recurrent pre-B-cell acute lymphoblastic leukemia in the middle ear: A form of granulocytic sarcoma

July 5, 2012     David Manning, MD; Enrique Palacios, MD, FACR; Harold Neitzschman, MD, FACR
article

Leukemia of the middle ear easily can be misidentified as acute otitis media or Bell palsy. It occurs most often in children 2 to 5 years of age and in the elderly population.

Huge middle ear adenoma with delayed facial nerve paralysis

June 4, 2012     Seung Ho Lee, MD; Hoseok Choi, MD, PhD; Young Chae Chu, MD; Young Hyo Kim, MD; Kyu-Sung Kim, MD, PhD
article

Abstract

Middle ear adenoma is a rare disease that arises from the mucosa of the middle ear. Only a few cases of associated facial nerve paralysis have been reported. Facial nerve involvement is most likely related to nerve compression rather than tumor invasion of the nerve. We describe a case of a huge middle ear adenoma in a 63-year-old man. He presented with a 1-month history of right-sided otalgia, otorrhea, and facial palsy; he also had a 10-year history of right-sided hearing loss. A tympanomastoidectomy was performed. Intraoperatively, the tumor was found to fill the middle ear cavity as well as the entire diameter of the external auditory canal. The tumor had eroded the wall of the facial canal at the second genu, and it was tightly adherent to the epineurium. Focal inflammation around the tumor was observed at the exposed facial nerve. The tumor was removed and the facial nerve was decompressed. Immediately after surgery, the patient’s aural symptoms resolved. The final pathology evaluation established the diagnosis of a middle ear adenoma. At the 3-year follow-up, the ear cavity was completely healed and facial nerve function was improved.

Otoscopic findings in otosclerosis

March 31, 2012     John C. Goddard, MD and Jose N. Fayad, MD
article

Only 10% of patients with otosclerosis exhibit the reddish hue of the Schwartze sign. It is believed to appear because of increased vascularity over the promontory in the middle ear.

Is there an ototoxicity risk from Cortisporin and comparable otic suspensions? Distortion-product otoacoustic emission findings

March 1, 2012     Leonard P. Berenholz, MD, Dyana L. Rossi, MA, William H. Lippy, MD, and John M. Burkey, MA
article

Abstract

The purpose of this investigation was to use distortion-product otoacoustic emission (DPOAE) testing to address the issue of possible ototoxicity from the use of neomycin/polymyxin B/hydrocortisone otic suspension following tympanostomy tube placement. We retrospectively reviewed our clinical records and identified 36 children (52 ears) who had met our three study criteria: (1) unilateral or bilateral placement of transtympanic ventilation tubes, (2) treatment for 3 to 5 days with neomycin/polymyxin B/hydrocortisone drops, and (3) postoperative evaluation by DPOAE testing. We identified another set of 36 children (52 ears) who had not received these drops and who had not undergone tube placement but who had been evaluated by DPOAE testing to serve as a control group. We found no significant differences in DPOAE amplitudes between the treatment and control groups. These findings are consistent with decades of clinical experience indicating that neomycin/polymyxin B/hydrocortisone otic suspension is safe when used responsibly.

Middle ear encephalocele: Not just another chronic ear

February 18, 2012     John C. Goddard, MD and Jose N. Fayad, MD
article

Squamous cell carcinoma of the middle ear

January 25, 2012     Min-Tsan Shu, MD, Jehn-Chuan Lee, MD, Cheng-Chien Yang, MD, and Kang-Chao Wu, MD
article
PreviousPage
of 12Next